Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Brand-Name Rx Rise After Docs Get Drug Company Perks: StudyAs Prices Rise for Parkinson's, Alzheimer's Meds, Patients Go WithoutRoll Up Your Sleeve and Donate Blood for Cancer PatientsShotguns Often Play Tragic Role in Rural Teens' Suicides: StudyPrice Hikes Have Patients Turning to Craigslist for Insulin, Asthma InhalersConsumers Waste Twice as Much Food as Experts ThoughtStricter Clean Air Laws Could Save Thousands of Lives a Year: StudyCaregivers Give Short Shrift to Their Own HealthMedicare Could Save Billions If Allowed to Negotiate Insulin PricesDentists Among Top Prescribers of OpioidsBedside 'Sitters' May Not Prevent Hospital FallsDoes Race Play a Part in ICU Outcomes?When Pharmacists Allowed to Give Anti-Opioid Med Without Rx, Access SoarsNew Study Supports Lowering Age of First ColonoscopyAgeism Affects People Around the GlobeLife Expectancy in U.S. Increases for First Time in 4 YearsJust 1% of Doctors Prescribe Nearly Half of Opioids in U.S.AHA News: These Doctors Want to Write 'Farmacy' PrescriptionsCan Online Reviews Help Health Inspectors Keep Tabs on Restaurants?AHA News: Can Social Media Be Good for Your Health?Flame Retardants, Pesticides Remain Threat to U.S. Health: StudySimple Tweak to Hospital Computer Program Cuts Opioid PrescriptionsJust 2% of Patients Who Need It Get Anti-Opioid Drug NaloxoneAre Doctors Discarding 'Injured' Kidneys That Might Be Used for Transplant?Probiotics: Don't Buy the Online HypeNew Drugs Getting FDA's Blessing Faster, but Is That a Good Thing?Would Tighter Swimming Rules at Public Beaches, Lakes and Rivers Save Lives?Seniors Still Wary of Online Reviews When Picking DoctorsMany Drugstores Misinform on Disposal of Unused MedsAHA News: Get Started on the Path to Better Health in the New YearAHA News: Bystander CPR Less Common in Hispanic NeighborhoodsPrepared Bystanders Save Lives When Cardiac Arrest StrikesVaccinations Rose After California Curbed ExemptionsSpecial 'Invisible' Dye Could Serve as Skin's Vaccination RecordGrowing Obesity Rates May Contribute to Climate ChangeHealth Tip: Do's and Don'ts While Waiting for an AmbulanceFDA to Allow States to Import Prescription Drugs From Other CountriesWhere Pot Is Legal, People Are Likely to Believe Its BenefitsFewer Americans Have a Primary Care Doctor NowHospital-Level Care in Your Home? It Could Be the FutureSleepy Nurses Could Put Patients at RiskTighter Alcohol Laws Might Help Curb CancerMany Young Adults Misusing Medical Marijuana, Study SuggestsAnother Possible Effect of Climate Change: More Preemie Babies1 in 18 U.S. Teens Carries a Gun to School: StudyU.S. Poison Centers Field More Calls About Psychoactive Substances: StudyDoctors' Group Calls for Ban on Most Vaping ProductsAs Disease Outbreaks Tied to 'Anti-Vaxxers' Rise, States Take ActionAHA News: Millions Who Never Smoked Cigarettes Are Using Other Tobacco ProductsMost Docs Don't Know Hair Care Is a Barrier to Exercise for Black Women
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

CBD Is the Rage, But More Science Needed on Safety, Effectiveness

HealthDay News
by -- Robert Preidt
Updated: Aug 22nd 2019

new article illustration

THURSDAY, Aug. 22, 2019 (HealthDay News) -- Everywhere you look, CBD products are for sale, and they may hold promise for treating chronic pain, opioid addiction and other conditions.

But a new review says more human clinical trials on the safety and effectiveness of cannabidiol (CBD) products are needed.

"There are many intriguing findings in pre-clinical studies that suggest CBD and hemp oil have anti-inflammatory effects and may be helpful with improving sleep and anxiety," said Dr. Brent Bauer, director of research for the Mayo Clinic Integrative Medicine program.

"But trials in humans are still limited, so it is too early to be definitive about efficacy and safety," he added in a Mayo Clinic news release.

There are a growing number of reports of liver injury in patients who've used CBD products, Bauer noted.

"Careful selection of a health care product is crucial, and though these products do not have [U.S.] Food and Drug Administration approval for therapeutic use, patients continue to ask for them and use them," he said. "Physicians need to become better informed about these products, and it's important that human trials examine issues of efficacy and safety."

Because many Americans are embracing CBD products, doctors should learn as much as possible about those products, Bauer suggested.

"We encourage physicians to not disregard their patients' interest in these products, and keep both a clinical curiosity and a healthy skepticism about the claims made," he said.

"Chronic pain management continues to challenge patients and physicians, and these therapies are a promising area that needs more research. For patients struggling with chronic pain, physicians taking time to listen to them and address their questions compassionately, but with an evidence-based approach, can help them make informed decisions," Bauer said.

The review found that limited regulation of CBD products is a concern for health care providers.

According to review co-author Dr. Karen Mauck, an internist at the Mayo Clinic in Rochester, Minn., "Other than Epidiolex -- a purified form of plant-derived CBD which was approved in 2018 for treatment of severe forms of epilepsy -- all other forms of CBD are not approved by the Food and Drug Administration, but are sold in a variety of formulations, including oral or topical oils, creams, sprays and tablets."

These formulations "contain variable amounts of CBD, may contain other active compounds and may have labeling inaccuracies. Before using CBD or hemp oils, it's important to consult with your physician about potential side effects and interactions with other medications," Mauck advised in the news release.

The review was published in the September issue of the journal Mayo Clinic Proceedings.

More information

The U.S. National Institutes of Health has more on cannabidiol.




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net